Natco’s marketing partner Mylan gets US FDA nod for multiple sclerosis drug
The launch plans for both will be communicated shortly after concurring with its partner Mylan
Author
Lonza to acquire US clinical manufacturing site
Site is being acquired from Shire and adds early-phase clinical manufacture on the West Coast
Novartis India invites applications for BioCamp 2017
Three winning students will get the opportunity to avail internship with Novartis India
Scientists develop technique for on-site printing of medications
Multiple medications can be printed into a single dose on a dissolvable strip, micro-needle patch or other dosing device
2nd Annual ACS Industry Symposium to be held in Mumbai
Discussions will be held on global challenges and recent advances in biologics and biosimilars
DRL launches Sevelamer Carbonate tabs in US
The tablets of 800 mg strength are available in the bottle count size of 270
Bharat Biotech’s Typbar-TCV vaccine confirms high efficacy in TCV human challenge study
According to the trial’s results published in The Lancet, the vaccine turned out to be 87 per cent effective for infants, older…
Indian pharma’s aggregate growth expected to come down to single digit
According to ICRA, the downfall will be led by limited near-term FTF generic opportunities and pricing pressure on base business
Lupin receives FDA approval for generic Acticlate tablets
They are indicated in the treatment of infections caused by various microorganisms and as an adjunctive therapy in severe acne
Mylan and Natsimbio in agreement for production of anti-HIV drugs in Russia
The agreement will help Natsimbio to produce a wide range of generics for HIV treatment